The Rogers Foundation announces a second landmark gift, building on its $130 million gift in 2014, to sustain the Ted Rogers Centre for Heart Research in perpetuity and bring the promise of precision cardiac health to patients across Canada and globally. In 2014, the...
Ted Rogers Chair in Heart Function Outcomes Dr. Douglas Lee leads new Heart-Brain Connection $3 million IMPACT Award project
Four unique educational events in October and December
Targeting heart failure in Indigenous communities
Our funded study reveals inequitable COVID-19 rates from the start
Remembering Loretta Rogers
All are welcome to join an ECHO webinar on Tuesday June 21, 2022 (11 am – 12 pm EST) featuring Dr. Harry Rowland (CEO and Co-founder, Endotronix).
Dr. Rowland’s presentation entitled, “Insights from the Endotronix Journey: A PMA Medtech “Startup” Story”, will feature an overview of Endotronix, its technologies and the story behind its success. Endotronix is a medical technology company, delivering an integrated platform that provides comprehensive, reimbursable health management innovations for patients suffering from advanced heart failure. Please see attachment for more details.
Register in advance for this webinar: https://us02web.zoom.us/meeting/register/tZwkc-GrqD0sGtcnluN7KLI2wNtAxZ1kYIx9
ECHO is an entrepreneurship training program, funded and organized in a partnership between (i) the Translational Biology and Engineering Program (TBEP), the University of Toronto component of the Ted Rogers Centre for Heart Research, and (ii) the Health Innovation Hub (H2i).